Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Does routine clinical practice reproduce the outcome of large prospective trials? The analysis of institutional database on patients with limited-disease small-cell lung cancer.

Wzietek I, Suwinski R, Nowara E, Bialas M, Bentzen S, Tukiendorf A.

Cancer Invest. 2014 Jan;32(1):1-7. doi: 10.3109/07357907.2013.861470. Epub 2013 Nov 26.

PMID:
24279320
2.

Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.

Winther-Larsen A, Hoffmann L, Moeller DS, Khalil AA, Knap MM.

Acta Oncol. 2015;54(9):1574-81. doi: 10.3109/0284186X.2015.1062135. Epub 2015 Jul 23.

PMID:
26203924
4.

Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.

Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK; London Lung Cancer Group.

J Clin Oncol. 2006 Aug 20;24(24):3823-30.

PMID:
16921033
5.

[Efficacy of chemotherapy combined hyperfractionated accelerated radiotherapy on limited small cell lung cancer].

Hu X, Bao Y, Chen YY, Gao JM, Wang WH, Liu Y, He H, Sun ZW, Poudel S, Wang Y, Zhuang TT, Zhang L, Chen M.

Ai Zheng. 2008 Oct;27(10):1088-93. Chinese.

PMID:
18851790
6.

Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.

Khanfir K, Elhfidh M, Anchisi S, Matzinger O, Bieri S, Mirimanoff RO, Ozsahin M, Zouhair A.

Swiss Med Wkly. 2011 May 31;141:w13205. doi: 10.4414/smw.2011.13205.

7.

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.

Colaco R, Sheikh H, Lorigan P, Blackhall F, Hulse P, Califano R, Ashcroft L, Taylor P, Thatcher N, Faivre-Finn C.

Lung Cancer. 2012 Apr;76(1):72-7. doi: 10.1016/j.lungcan.2011.09.015. Epub 2011 Oct 19.

PMID:
22014897
8.

Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.

Reck M, Thatcher N, Smit EF, Lorigan P, Szutowicz-Zielinska E, Liepa AM, Winfree KB, Peterson P, Guba SC, Socinski MA.

Lung Cancer. 2012 Dec;78(3):276-81. doi: 10.1016/j.lungcan.2012.09.002. Epub 2012 Oct 6.

PMID:
23043970
9.

Practice guideline on prophylactic cranial irradiation in small-cell lung cancer.

Kotalik J, Yu E, Markman BR, Evans WK; Cancer Ontario Practice Guidelines Initiative Lung Cancer Disease Site Group.

Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):309-16.

PMID:
11380216
10.

Management of small-cell lung cancer: incremental changes but hope for the future.

Hann CL, Rudin CM.

Oncology (Williston Park). 2008 Nov 30;22(13):1486-92. Review.

11.

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.

PMID:
9765750
12.

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).

Schild SE, Bonner JA, Hillman S, Kozelsky TF, Vigliotti AP, Marks RS, Graham DL, Soori GS, Kugler JW, Tenglin RC, Wender DB, Adjei A.

J Clin Oncol. 2007 Jul 20;25(21):3124-9.

PMID:
17634491
13.

Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).

Thomas CR Jr, Giroux DJ, Stelzer KJ, Craig JB, Laufman LR, Taylor SA, Goodwin JW, Crowley JJ, Livingston RB.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1039-47.

PMID:
9539558
14.

Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity.

Ramlov A, Tietze A, Khalil AA, Knap MM.

Lung Cancer. 2012 Sep;77(3):561-6. doi: 10.1016/j.lungcan.2012.05.101. Epub 2012 Jun 5.

PMID:
22677428
15.

Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.

Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH.

Lung Cancer. 2015 Nov;90(2):243-8. doi: 10.1016/j.lungcan.2015.08.002. Epub 2015 Aug 8.

PMID:
26277031
16.

Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.

Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.

Jpn J Clin Oncol. 1994 Oct;24(5):275-81.

PMID:
7967106
18.

The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer.

Lee KJ, Lee EJ, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Yoo SH, Lee SY.

Korean J Intern Med. 2013 Jul;28(4):449-55. doi: 10.3904/kjim.2013.28.4.449. Epub 2013 Jul 1.

19.

Radiotherapy in small-cell lung cancer: where should it go?

Paumier A, Le Péchoux C.

Lung Cancer. 2010 Aug;69(2):133-40. doi: 10.1016/j.lungcan.2010.04.019. Epub 2010 Jun 1. Review.

PMID:
20605651
20.

Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.

Li J, Chen P, Dai CH, Li XQ, Bao QL.

Geriatr Gerontol Int. 2009 Jun;9(2):172-82. doi: 10.1111/j.1447-0594.2009.00525.x.

PMID:
19740361

Supplemental Content

Support Center